Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 98099423 | 9809942 | 3 | F | 201111 | 20160810 | 20140110 | 20160819 | EXP | US-SANOFI-AVENTIS-2013SA068250 | AVENTIS | 61.39 | YR | A | M | Y | 0.00000 | 20160819 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 98099423 | 9809942 | 1 | PS | PLAVIX | CLOPIDOGREL BISULFATE | 1 | Unknown | U | UNKNOWN | 20839 | 75 | MG | TABLET | QD | |||||
| 98099423 | 9809942 | 2 | C | ASPIRIN. | ASPIRIN | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 98099423 | 9809942 | 1 | Stent placement |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 98099423 | 9809942 | OT |
| 98099423 | 9809942 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 98099423 | 9809942 | Gastric disorder | |
| 98099423 | 9809942 | Gastrointestinal haemorrhage | |
| 98099423 | 9809942 | Lung neoplasm malignant | |
| 98099423 | 9809942 | Ulcer haemorrhage |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 98099423 | 9809942 | 1 | 2006 | 20111121 | 0 |